Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

The assay was reworked as a consequence ... and third- and fourth-generation tests offer very high performances. Immunoassays must be correctly selected and used for the population being tested.

Their relatively narrow dynamic range often requires testing more than one sample dilution ... using sample volumes as low as 1 μl in total assay volumes of 10 μl. Assays can be performed ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

The purchase includes the manufacturing process of four ELISA kits, two of which are in vitro diagnostic products for specialty diagnostics and disease monitoring.

The automated DxC 500 I analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.

There are several types of these tests. An immunoassay (IA) test is most common because it is the quickest and most cost-effective. However, IA tests can give false-positive results. In this case ...

With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.